Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series
BackgroundExtensive and complex head and neck lymphatic malformations (LMs) are challenging to manage through traditional therapy. The purpose of this retrospective study was to assess the efficacy and safety of sirolimus in infants with refractory head and neck LMs.MethodsSirolimus was administered...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.616702/full |
_version_ | 1819154320107503616 |
---|---|
author | Changhua Wu Dan Song Lei Guo Liang Wang |
author_facet | Changhua Wu Dan Song Lei Guo Liang Wang |
author_sort | Changhua Wu |
collection | DOAJ |
description | BackgroundExtensive and complex head and neck lymphatic malformations (LMs) are challenging to manage through traditional therapy. The purpose of this retrospective study was to assess the efficacy and safety of sirolimus in infants with refractory head and neck LMs.MethodsSirolimus was administered orally on a continuous dosing schedule. Patients were seen every month for the first three months and then subsequently every three months. The primary endpoints were safety and efficacy based on clinical and radiological evaluations.ResultsEight patients, refractory to standard care, were enrolled and received sirolimus continuously. After 12 months of follow-up, the response and safety to medication was evaluated: all patients experienced reductions in LMs bulk, ranging from modest to significant. Some minor adverse effects were reported: mouth sores, eczema, gastrointestinal reaction, dyslipidemia, and neutropenia.ConclusionSirolimus was efficient in children with refractory head and neck LMs and was well tolerated. |
first_indexed | 2024-12-22T15:19:12Z |
format | Article |
id | doaj.art-7fa259ba00a3462582727c69a3ea74e6 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-22T15:19:12Z |
publishDate | 2021-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-7fa259ba00a3462582727c69a3ea74e62022-12-21T18:21:40ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-07-011110.3389/fonc.2021.616702616702Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case SeriesChanghua WuDan SongLei GuoLiang WangBackgroundExtensive and complex head and neck lymphatic malformations (LMs) are challenging to manage through traditional therapy. The purpose of this retrospective study was to assess the efficacy and safety of sirolimus in infants with refractory head and neck LMs.MethodsSirolimus was administered orally on a continuous dosing schedule. Patients were seen every month for the first three months and then subsequently every three months. The primary endpoints were safety and efficacy based on clinical and radiological evaluations.ResultsEight patients, refractory to standard care, were enrolled and received sirolimus continuously. After 12 months of follow-up, the response and safety to medication was evaluated: all patients experienced reductions in LMs bulk, ranging from modest to significant. Some minor adverse effects were reported: mouth sores, eczema, gastrointestinal reaction, dyslipidemia, and neutropenia.ConclusionSirolimus was efficient in children with refractory head and neck LMs and was well tolerated.https://www.frontiersin.org/articles/10.3389/fonc.2021.616702/fulllymphatic malformationsirolimushead and necksclerotherapyinfant |
spellingShingle | Changhua Wu Dan Song Lei Guo Liang Wang Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series Frontiers in Oncology lymphatic malformation sirolimus head and neck sclerotherapy infant |
title | Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series |
title_full | Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series |
title_fullStr | Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series |
title_full_unstemmed | Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series |
title_short | Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series |
title_sort | refractory head and neck lymphatic malformation in infants treated with sirolimus a case series |
topic | lymphatic malformation sirolimus head and neck sclerotherapy infant |
url | https://www.frontiersin.org/articles/10.3389/fonc.2021.616702/full |
work_keys_str_mv | AT changhuawu refractoryheadandnecklymphaticmalformationininfantstreatedwithsirolimusacaseseries AT dansong refractoryheadandnecklymphaticmalformationininfantstreatedwithsirolimusacaseseries AT leiguo refractoryheadandnecklymphaticmalformationininfantstreatedwithsirolimusacaseseries AT liangwang refractoryheadandnecklymphaticmalformationininfantstreatedwithsirolimusacaseseries |